×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
IQWiG-Berichte – Nr. 469 Idelalisib (chronische lymphatische … · 2020-01-24 · Idelalisib, Rituximab, Ofatumumab, Leukemia – Lymphocytic – Chronic – B-Cell, Benefit Assessment
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form